Nano-X Imaging (NNOX) Non Operating Investment Income (2021 - 2025)

Nano-X Imaging (NNOX) posted quarterly Non Operating Investment Income of -$1000.0 for Q3 2025, down 101.52% year-on-year from $66000.0 in Q3 2024, and down 125.0% on a QoQ basis from $4000.0 in Q2 2025.

Nano-X Imaging (NNOX) Non Operating Investment Income (2021 - 2025) Analysis & Trends

Nano-X Imaging (NNOX) has reported Non Operating Investment Income for 5 consecutive years, with -$1000.0 the latest figure, recorded in Q3 2025.

  • Quarterly Non Operating Investment Income fell 101.52% year-over-year to -$1000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 99.67% YoY) and the FY2025 annual result came in at $1000.0, down 99.67% from the prior year.
  • Non Operating Investment Income fell to -$1000.0 in Q3 2025 per NNOX's latest filing, from $4000.0 in the prior quarter.
  • Over the last five years, Non Operating Investment Income for NNOX reached as high as $485000.0 in Q4 2022 and fell as low as -$1.4 million in Q1 2022.
  • A 5-year average of -$88400.0 and a median of -$2000.0 in 2025 frame the typical range for Non Operating Investment Income.
  • The largest YoY upside for Non Operating Investment Income was 216.31% in 2022 against a maximum downside of 243.24% in 2022.
  • Year by year, Non Operating Investment Income stood at -$417000.0 in 2021, then soared by 216.31% to $485000.0 in 2022, then fell by 29.69% to $341000.0 in 2023, then tumbled by 103.81% to -$13000.0 in 2024, then soared by 92.31% to -$1000.0 in 2025.
  • According to Business Quant data, Non Operating Investment Income over the past three periods registered -$1000.0, $4000.0, and -$2000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Nano-X Imaging 62,810.26 -44.16 Mn -2.59 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,000.00
Sep 30, 2025 -1,000.00
Jun 30, 2025 4,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 -2,000.00
Mar 31, 2025 -2,000.00
Dec 31, 2024 -13,000.00
Dec 31, 2024 -13,000.00
Sep 30, 2024 66,000.00
Sep 30, 2024 66,000.00
Jun 30, 2024 66,000.00
Jun 30, 2024 66,000.00
Mar 31, 2024 187,000.00
Mar 31, 2024 187,000.00
Dec 31, 2023 341,000.00
Dec 31, 2023 341,000.00
Dec 31, 2022 485,000.00
Dec 31, 2022 485,000.00
Sep 30, 2022 -254,000.00
Sep 30, 2022 -254,000.00